GB0703909D0 - Treatment of anxiety disorders - Google Patents

Treatment of anxiety disorders

Info

Publication number
GB0703909D0
GB0703909D0 GBGB0703909.2A GB0703909A GB0703909D0 GB 0703909 D0 GB0703909 D0 GB 0703909D0 GB 0703909 A GB0703909 A GB 0703909A GB 0703909 D0 GB0703909 D0 GB 0703909D0
Authority
GB
United Kingdom
Prior art keywords
treatment
anxiety disorders
anxiety
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0703909.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROPHARM Ltd
Original Assignee
NEUROPHARM Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROPHARM Ltd filed Critical NEUROPHARM Ltd
Priority to GBGB0703909.2A priority Critical patent/GB0703909D0/en
Publication of GB0703909D0 publication Critical patent/GB0703909D0/en
Priority to PCT/GB2008/000504 priority patent/WO2008104734A1/en
Priority to AU2008220668A priority patent/AU2008220668A1/en
Priority to EP08709396A priority patent/EP2129383A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0703909.2A 2007-02-28 2007-02-28 Treatment of anxiety disorders Ceased GB0703909D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0703909.2A GB0703909D0 (en) 2007-02-28 2007-02-28 Treatment of anxiety disorders
PCT/GB2008/000504 WO2008104734A1 (en) 2007-02-28 2008-02-14 Treatment of anxiety disorders with minocycline
AU2008220668A AU2008220668A1 (en) 2007-02-28 2008-02-14 Treatment of anxiety disorders with minocycline
EP08709396A EP2129383A1 (en) 2007-02-28 2008-02-14 Treatment of anxiety disorders with minocycline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0703909.2A GB0703909D0 (en) 2007-02-28 2007-02-28 Treatment of anxiety disorders

Publications (1)

Publication Number Publication Date
GB0703909D0 true GB0703909D0 (en) 2007-04-11

Family

ID=37965686

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0703909.2A Ceased GB0703909D0 (en) 2007-02-28 2007-02-28 Treatment of anxiety disorders

Country Status (4)

Country Link
EP (1) EP2129383A1 (en)
AU (1) AU2008220668A1 (en)
GB (1) GB0703909D0 (en)
WO (1) WO2008104734A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.
GB201902580D0 (en) * 2019-02-26 2019-04-10 Healx Ltd Treatment
GB201910755D0 (en) * 2019-07-26 2019-09-11 Healx Ltd Treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209690D1 (en) * 1992-02-25 1999-06-10 Spirig Ag Pellets containing minocycline
WO1999033455A1 (en) * 1997-12-30 1999-07-08 Bioabsorbable Concepts, Inc. Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
WO2004078111A2 (en) * 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation

Also Published As

Publication number Publication date
WO2008104734A1 (en) 2008-09-04
EP2129383A1 (en) 2009-12-09
AU2008220668A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
GB0703909D0 (en) Treatment of anxiety disorders
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
EP2175873A4 (en) Treatment for anxiety
ZA201102640B (en) Use of scyllo-inositols for the treatment of macular degeneration-related disorders
IL194189A0 (en) Combination treatment of metabolic disorders
ZA201107449B (en) Compounds for the treatment of metabolic disorders
EP2120930A4 (en) Use of chromium histidinate for treatment of cardiometabolic disorders
ZA201107446B (en) Compounds for the treatment of metabolic disorders
GB0904284D0 (en) Compounds for the treatment of metabolic disorders
HRP20171418T1 (en) Therapeutic agent for anxiety disorders
ZA201001705B (en) Azithromycin for treatment of skin disorders
GB0809476D0 (en) Treatment of neurodegenerative disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
IL210558A0 (en) Treatment of anxiety disorders
EP2099444A4 (en) Use of d-serine derivatives for the treatment of anxiety disorders
EP2164494A4 (en) Methods of treatment
GB0723100D0 (en) Treatment of HFnEF
EP2212246B1 (en) Treatment of neurological disorders
PT2278962E (en) Methods for the treatment of dermatological disorders
HK1145282A1 (en) Treatment of sleep disorders
ZA201100325B (en) Treatment of anxiety disorders
GB0819446D0 (en) Treatment of inflammatory disorders
GB0808623D0 (en) Treatment of keratinizing disorders
EP2124957A4 (en) Methods of treating mood disorders
GB0814043D0 (en) The treatment of skin disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)